
Tianjin Medical Journal ›› 2025, Vol. 53 ›› Issue (12): 1270-1275.doi: 10.11958/20252583
• Clinical Research • Previous Articles Next Articles
XU Yong(
), SUN Jie(
), HU Zongju
Received:2025-07-25
Revised:2025-09-10
Published:2025-12-15
Online:2025-12-08
Contact:
△E-mail:XU Yong, SUN Jie, HU Zongju. Analysis of influencing factors and construction of prediction model in patients with severe acute pancreatitis complicated with acute acalculous cholecystitis[J]. Tianjin Medical Journal, 2025, 53(12): 1270-1275.
CLC Number:
| 组别 | n | 年龄/岁 | 男性 | 吸烟 | 饮酒 | BMI/(kg/m2) | 禁食水时间/d | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非AAC组 | 156 | 52.35±7.38 | 108(69.23) | 53(33.97) | 70(44.87) | 23.18±1.94 | 7.63±2.08 | ||||||
| AAC组 | 64 | 54.17±8.83 | 41(64.06) | 24(37.50) | 21(32.81) | 22.69±2.07 | 10.25±2.87 | ||||||
| χ2或t | 1.459 | 0.555 | 0.248 | 2.721 | 1.644 | 6.621** | |||||||
| 组别 | SAP病因 | 基础疾病 | 脓毒症 | ||||||||||
| 高脂血症性 | 酒精性 | 特发性 | 其他 | 高血压 | 糖尿病 | ||||||||
| 非AAC组 | 56(35.90) | 60(38.46) | 23(14.74) | 17(10.90) | 58(37.18) | 24(15.38) | 23(14.74) | ||||||
| AAC组 | 26(40.63) | 15(23.44) | 10(15.63) | 13(20.31) | 30(46.88) | 16(25.00) | 18(28.13) | ||||||
| χ2 | 6.250 | 1.778 | 2.821 | 5.359* | |||||||||
Tab.1 Comparison of general clinical data between the 2 groups of patients
| 组别 | n | 年龄/岁 | 男性 | 吸烟 | 饮酒 | BMI/(kg/m2) | 禁食水时间/d | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非AAC组 | 156 | 52.35±7.38 | 108(69.23) | 53(33.97) | 70(44.87) | 23.18±1.94 | 7.63±2.08 | ||||||
| AAC组 | 64 | 54.17±8.83 | 41(64.06) | 24(37.50) | 21(32.81) | 22.69±2.07 | 10.25±2.87 | ||||||
| χ2或t | 1.459 | 0.555 | 0.248 | 2.721 | 1.644 | 6.621** | |||||||
| 组别 | SAP病因 | 基础疾病 | 脓毒症 | ||||||||||
| 高脂血症性 | 酒精性 | 特发性 | 其他 | 高血压 | 糖尿病 | ||||||||
| 非AAC组 | 56(35.90) | 60(38.46) | 23(14.74) | 17(10.90) | 58(37.18) | 24(15.38) | 23(14.74) | ||||||
| AAC组 | 26(40.63) | 15(23.44) | 10(15.63) | 13(20.31) | 30(46.88) | 16(25.00) | 18(28.13) | ||||||
| χ2 | 6.250 | 1.778 | 2.821 | 5.359* | |||||||||
| 组别 | PLT/(×109/L) | PCT/(μg/L) | ALT/(U/L) | AST/(U/L) | TBil/(μmol/L) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 非AAC组 | 197.40±39.00 | 0.66±0.19 | 50.81±9.97 | 46.49±10.87 | 26.39±8.87 | ||||||
| AAC组 | 208.86±47.29 | 0.70±0.20 | 52.75±10.48 | 48.76±11.64 | 32.65±10.48 | ||||||
| t | 1.714 | 1.721 | 1.292 | 1.384 | 4.512** | ||||||
| 组别 | n | AMY/(U/L) | LIP/(U/L) | SIRI | CAR | WMR | |||||
| 非AAC组 | 156 | 535.75±101.39 | 413.86±87.29 | 5.06(3.98,6.62) | 3.68(2.67,4.81) | 1.19±0.23 | |||||
| AAC组 | 64 | 517.81±123.66 | 433.87±90.43 | 7.44(4.73,10.38) | 4.33(3.69,5.41) | 1.28±0.30 | |||||
| t或Z | 1.027 | 1.529 | 4.028** | 2.997** | 2.269* | ||||||
Tab.2 Comparison of laboratory indexes between the 2 groups of patients
| 组别 | PLT/(×109/L) | PCT/(μg/L) | ALT/(U/L) | AST/(U/L) | TBil/(μmol/L) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 非AAC组 | 197.40±39.00 | 0.66±0.19 | 50.81±9.97 | 46.49±10.87 | 26.39±8.87 | ||||||
| AAC组 | 208.86±47.29 | 0.70±0.20 | 52.75±10.48 | 48.76±11.64 | 32.65±10.48 | ||||||
| t | 1.714 | 1.721 | 1.292 | 1.384 | 4.512** | ||||||
| 组别 | n | AMY/(U/L) | LIP/(U/L) | SIRI | CAR | WMR | |||||
| 非AAC组 | 156 | 535.75±101.39 | 413.86±87.29 | 5.06(3.98,6.62) | 3.68(2.67,4.81) | 1.19±0.23 | |||||
| AAC组 | 64 | 517.81±123.66 | 433.87±90.43 | 7.44(4.73,10.38) | 4.33(3.69,5.41) | 1.28±0.30 | |||||
| t或Z | 1.027 | 1.529 | 4.028** | 2.997** | 2.269* | ||||||
| 变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
|---|---|---|---|---|---|---|
| 禁食水时间 | 0.444 | 0.089 | 25.005 | <0.001 | 1.559 | 1.310~1.855 |
| 脓毒症 | 0.559 | 0.467 | 1.430 | 0.232 | 1.748 | 0.700~4.366 |
| SIRI | 0.217 | 0.060 | 12.998 | <0.001 | 1.242 | 1.104~1.398 |
| CAR | 0.278 | 0.124 | 5.038 | 0.025 | 1.321 | 1.036~1.684 |
| WMR | 1.869 | 0.807 | 5.364 | 0.021 | 6.480 | 1.333~31.508 |
| TBil | 0.053 | 0.021 | 6.430 | 0.011 | 1.054 | 1.012~1.098 |
| 常数项 | -11.364 | 1.751 | 42.100 | <0.001 | 0.000 |
Tab.3 Multivariate Logistic regression analysis of AAC in patients with SAP
| 变量 | β | SE | Wald χ2 | P | OR | OR 95%CI |
|---|---|---|---|---|---|---|
| 禁食水时间 | 0.444 | 0.089 | 25.005 | <0.001 | 1.559 | 1.310~1.855 |
| 脓毒症 | 0.559 | 0.467 | 1.430 | 0.232 | 1.748 | 0.700~4.366 |
| SIRI | 0.217 | 0.060 | 12.998 | <0.001 | 1.242 | 1.104~1.398 |
| CAR | 0.278 | 0.124 | 5.038 | 0.025 | 1.321 | 1.036~1.684 |
| WMR | 1.869 | 0.807 | 5.364 | 0.021 | 6.480 | 1.333~31.508 |
| TBil | 0.053 | 0.021 | 6.430 | 0.011 | 1.054 | 1.012~1.098 |
| 常数项 | -11.364 | 1.751 | 42.100 | <0.001 | 0.000 |
| [1] | HAMESCH K, HOLLENBACH M, GUILABERT L, et al. Practical management of severe acute pancreatitis[J]. Eur J Intern Med, 2025, 133:1-13. doi:10.1016/j.ejim.2024.10.030. |
| [2] | RODRIGUES T, BOIKE J R. Biliary strictures:etiologies and medical management[J]. Semin Intervent Radiol, 2021, 38(3):255-262. doi:10.1055/s-0041-1731086. |
| [3] | MORIKAWA T, AKADA M, SHIMIZU K, et al. Current status and therapeutic strategy of acute acalculous cholecystitis:Japanese nationwide survey in the era of the Tokyo guidelines[J]. J Hepatobiliary Pancreat Sci, 2024, 31(3):162-172. doi:10.1002/jhbp.1401. |
| [4] | 李启元, 罗岩, 孙备. 急性胰腺炎并发胆道系统疾病的诊治进展[J]. 中华外科杂志, 2025, 63(1):76-80. |
| LI Q Y, LUO Y, SUN B. Progress in the diagnosis and treatment of acute pancreatitis complicated by biliary tract diseases[J]. Chin J Surg, 2025, 63(1):76-80. doi:10.3760/cma.j.cn112139-20240708-00330. | |
| [5] | MOSSAAB G, BEN KHLIFA M, KARIM N, et al. Acute acalculous cholecystitis in hospitalized patients in intensive care unit:study of 5 cases[J]. Heliyon, 2022, 8(11):e11524. doi:10.1016/j.heliyon.2022.e11524. |
| [6] | ISLAM M M, SATICI M O, EROGLU S E. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio,platelet-to-lymphocyte ratio,systemic immune-inflammation index,systemic inflammation response index,and delta neutrophil index:an extensive literature review[J]. Turk J Emerg Med, 2024, 24(1):8-19. doi:10.4103/tjem.tjem_198_23. |
| [7] | LIU J, CHEN X, YANG M, et al. C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with Kawasaki disease:a systematic review of cohort studies[J]. Pediatr Rheumatol Online J, 2024, 22(1):42. doi:10.1186/s12969-024-00980-6. |
| [8] | WANG Y, MIAO Y, WAN Q. Association of white blood cell count to mean platelet volume ratio with type 2 diabetic peripheral neuropathy in a Chinese population:a cross-sectional study[J]. BMC Endocr Disord, 2024, 24(1):129. doi:10.1186/s12902-024-01644-y. |
| [9] | 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华外科杂志, 2021, 59(7):578-587. |
| Study Group of Pancreatic Surgery in China Society of Surgery of Chinese Medical Association. Chinese guidelines for the management of acute pancreatitis(2021)[J]. Chin J Surg, 2021, 59(7):578-587. doi:10.3760/cma.j.cn112139-20210416-00172. | |
| [10] | YOKOE M, HATA J, TAKADA T, et al. Tokyo Guidelines 2018:diagnostic criteria and severity grading of acute cholecystitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1):41-54. doi:10.1002/jhbp.515. |
| [11] | HUANG S S, LIN K W, LIU K L, et al. Diagnostic performance of ultrasound in acute cholecystitis:a systematic review and meta-analysis[J]. World J Emerg Surg, 2023, 18(1):54. doi:10.1186/s13017-023-00524-5. |
| [12] | 刘振, 张旭, 张保平, 等. 内镜下逆行胰胆管造影术后非结石性急性胆囊炎风险因素分析[J]. 中国实用外科杂志, 2024, 44(10):1165-1170. |
| LIU Z, ZHANG X, ZHANG B P, et al. Study on risk factors of post-endoscopic retrograde cholangiopancreatography acalculous acute cholecystitis[J]. Chin J Pract Surg, 2024, 44(10):1165-1170. doi:10.19538/j.cjps.issn1005-2208.2024.10.17. | |
| [13] | UWATOKO R, KANI N, MAKINO S, et al. Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome with recurrent acute cholecystitis:a case report[J]. CEN Case Rep, 2024, 13(3):215-219. doi:10.1007/s13730-023-00831-5. |
| [14] | 李启元, 罗岩, 陈华, 等. 重症急性胰腺炎并发胆道系统疾病的临床特征及危险因素分析[J]. 中华外科杂志, 2025, 63(8):712-719. |
| LI Q Y, LUO Y, CHEN H, et al. Analysis of clinical features and risk factors for severe acute pancreatitis complicated with biliary system diseases[J]. Chin J Surg, 2025, 63(8):712-719. doi:10.3760/cma.j.cn112139-20250217-00080. | |
| [15] | GALLAHER J R, CHARLES A. Acute cholecystitis:a review[J]. JAMA, 2022, 327(10):965-975. doi:10.1001/jama.2022.2350. |
| [16] | 赵经委, 侯煜铖, 杨自逸, 等. 肠道菌群在胆道良性疾病中致病作用的全基因组孟德尔随机化研究[J]. 中华外科杂志, 2024, 62(3):216-222. |
| ZHAO J W, HOU Y C, YANG Z Y, et al. Genome-wide Mendelian randomization study of the pathogenic role of gut microbiota in benign biliary tract diseases[J]. Chin J Surg, 2024, 62(3):216-222. doi:10.3760/cma.j.cn112139-20230714-00008. | |
| [17] | JIN X, JIANG Y, TANG J. Ultrasound-guided percutaneous transhepatic gallbladder drainage improves the prognosis of patients with severe acute cholecystitis[J]. Evid Based Complement Alternat Med, 2022,2022:5045869. doi:10.1155/2022/5045869. |
| [18] | 董丹, 陈立娟, 俞荷花. 急性胰腺炎并发低血压的危险因素分析及预测模型建立[J]. 天津医药, 2025, 53(5):509-513. |
| DONG D, CHEN L J, YU H H. Analysis of risk factors and establishment of prediction model of acute pancreatitis complicated with hypotension[J]. Tianjin Med J, 2025, 53(5):509-513. doi:10.11958/20250456. | |
| [19] | 鲍布和, 张琪, 李海林, 等. 血常规比值参数在类风湿关节炎中的诊断价值[J]. 天津医药, 2023, 51(11):1271-1275. |
| BAO B H, ZHANG Q, LI H L, et al. Diagnostic value of blood cell count-derived ratio parameters in rheumatoid arthritis[J]. Tianjin Med J, 2023, 51(11):1271-1275. doi:10.11958/20230481. | |
| [20] | 徐家丹, 戴签, 王中新. 全身免疫炎症指数对中度重症和重症急性胰腺炎的预测价值[J]. 重庆医学, 2023, 52(14):2175-2179. |
| XU J D, DAI Q, WANG Z X. Predictive value of systemic immune inflammation index for moderate-severe and severe acute pancreatitis[J]. Chongqing Med, 2023, 52(14):2175-2179. doi:10.3969/j.issn.1671-8348.2023.14.017. | |
| [21] | FU Y, PANG L, DAI W, et al. Advances in the study of acute acalculous cholecystitis:a comprehensive review[J]. Dig Dis, 2022, 40(4):468-478. doi:10.1159/000520025. |
| [22] | CAKCAK İ E, KULA O. Predictive evaluation of SIRI,SII,PNI,and GPS in cholecystostomy application in patients with acute cholecystitis[J]. Ulus Travma Acil Cerrahi Derg, 2022, 28(7):940-946. doi:10.14744/tjtes.2022.90249. |
| [23] | 付玉茹, 孙振康, 刘成, 等. C反应蛋白/白蛋白比值与重症肺炎患者病情严重程度的关系及其对28 d死亡风险的预测价值[J]. 解放军医学杂志, 2025, 50(3):309-317. |
| FU Y R, SUN Z K, LIU C, et al. Relationship between C-reactive protein/albumin ratio and severity in patients with severe pneumonia and its predictive value for 28-day mortality risk[J]. Med J Chin PLA, 2025, 50(3):309-317. doi:10.11855/j.issn.0577-7402.0345.2024.1215. | |
| [24] | BOCCATONDA A, CAMPELLO E, TALLARICO V, et al. Splanchnic venous thrombosis in patients with acute cholecystitis:a case series and review of literature[J]. J Ultrasound, 2025, 28(3):551-561. doi:10.1007/s40477-025-01029-4. |
| [25] | ÖZDEMIR S, ALTUNOK I, ÖZKAN A, et al. Relationship between platelet indices in acute cholecystitis:a case-control study[J]. Rev Gastroenterol Mex(Engl Ed), 2024, 89(2):232-236. doi:10.1016/j.rgmxen.2023.04.012. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||